188 related articles for article (PubMed ID: 16529537)
1. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy.
Renner MW; Miura M; Easson MW; Vicente MG
Anticancer Agents Med Chem; 2006 Mar; 6(2):145-57. PubMed ID: 16529537
[TBL] [Abstract][Full Text] [Related]
2. Application of a novel boronated porphyrin (H₂OCP) as a dual sensitizer for both PDT and BNCT.
Hiramatsu R; Kawabata S; Miyatake S; Kuroiwa T; Easson MW; Vicente MG
Lasers Surg Med; 2011 Jan; 43(1):52-8. PubMed ID: 21254143
[TBL] [Abstract][Full Text] [Related]
3. Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.
Hiramatsu R; Kawabata S; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake S; Kuroiwa T; Hao E; Vicente MG
J Pharm Sci; 2015 Mar; 104(3):962-70. PubMed ID: 25546823
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.
Asano R; Nagami A; Fukumoto Y; Miura K; Yazama F; Ito H; Sakata I; Tai A
Bioorg Med Chem Lett; 2014 Mar; 24(5):1339-43. PubMed ID: 24508130
[TBL] [Abstract][Full Text] [Related]
5. The synthesis and use of boronated amino acids for boron neutron capture therapy.
Kabalka GW; Yao ML
Anticancer Agents Med Chem; 2006 Mar; 6(2):111-25. PubMed ID: 16529535
[TBL] [Abstract][Full Text] [Related]
6. Boron-containing protoporphyrin IX derivatives and their modification for boron neutron capture therapy: synthesis, characterization, and comparative in vitro toxicity evaluation.
El-Zaria ME; Ban HS; Nakamura H
Chemistry; 2010 Feb; 16(5):1543-52. PubMed ID: 20020518
[TBL] [Abstract][Full Text] [Related]
7. Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy.
Popova T; Dymova MA; Koroleva LS; Zakharova OD; Lisitskiy VA; Raskolupova VI; Sycheva T; Taskaev S; Silnikov VN; Godovikova TS
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770947
[TBL] [Abstract][Full Text] [Related]
8. Boron-containing chlorins and tetraazaporphyrins: synthesis and cell uptake of boronated pyropheophorbide a derivatives.
Ratajski M; Osterloh J; Gabel D
Anticancer Agents Med Chem; 2006 Mar; 6(2):159-66. PubMed ID: 16529538
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of new BSH-conjugated chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.
Asano R; Nagami A; Fukumoto Y; Miura K; Yazama F; Ito H; Sakata I; Tai A
J Photochem Photobiol B; 2014 Nov; 140():140-9. PubMed ID: 25123528
[TBL] [Abstract][Full Text] [Related]
10. Tracing Boron with Fluorescence and Positron Emission Tomography Imaging of Boronated Porphyrin Nanocomplex for Imaging-Guided Boron Neutron Capture Therapy.
Shi Y; Li J; Zhang Z; Duan D; Zhang Z; Liu H; Liu T; Liu Z
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43387-43395. PubMed ID: 30451482
[TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
Barth RF; Soloway AH; Brugger RM
Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
[TBL] [Abstract][Full Text] [Related]
12. Targeted drug delivery for boron neutron capture therapy.
Mehta SC; Lu DR
Pharm Res; 1996 Mar; 13(3):344-51. PubMed ID: 8692724
[TBL] [Abstract][Full Text] [Related]
13. Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy.
Wyzlic IM; Tjarks W; Soloway AH; Anisuzzaman AK; Rong FG; Barth RF
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1203-13. PubMed ID: 8175406
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
[TBL] [Abstract][Full Text] [Related]
15. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.
Jori G; Soncin M; Friso E; Vicente MG; Hao E; Miotto G; Colautti P; Moro D; Esposito J; Rosi G; Nava E; Sotti G; Fabris C
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S321-4. PubMed ID: 19376726
[TBL] [Abstract][Full Text] [Related]
16. Neutral and polyanionic carboranylporphyrazines: synthesis and physico-chemical properties.
Pietrangeli D; Ricciardi G
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S97-S100. PubMed ID: 19375333
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel carboranylchlorins with dual application in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT).
Luguya R; Fronczek FR; Smith KM; Vicente MG
Appl Radiat Isot; 2004 Nov; 61(5):1117-23. PubMed ID: 15308202
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.
Miura M; Micca PL; Fisher CD; Gordon CR; Heinrichs JC; Slatkin DN
Br J Radiol; 1998 Jul; 71(847):773-81. PubMed ID: 9771389
[TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy of primary and metastatic brain tumors.
Barth RF; Soloway AH
Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
[TBL] [Abstract][Full Text] [Related]
20. Carboranylporphyrins for boron neutron capture therapy of cancer.
Evstigneeva RP; Zaitsev AV; Luzgina VN; Ol' Shevskaya VA; Shtil AA
Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):383-92. PubMed ID: 14529446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
